Overview
Nils Meland practices practicing medicine in Oslo, Norway.
His clinical expertise encompasses Stargardt Macular Degeneration, Cystic Fibrosis, and Kidney Transplant.
He is actively involved in clinical research, co-authoring 11 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Nils Meland
Is Nils Meland a top-rated expert for Stargardt Macular Degeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Nils Meland is classified as an Experienced expert for Stargardt Macular Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Nils Meland participate in research or clinical trials?
Yes. Nils Meland has published 11 articles and abstracts on conditions like Stargardt Macular Degeneration. You can view a list of Nils Meland's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Cystic FibrosisMr. Meland isExperienced. Learn about Cystic Fibrosis.
- Kidney TransplantMr. Meland isExperienced. Learn about Kidney Transplant.
- Stargardt Macular DegenerationMr. Meland isExperienced. Learn about Stargardt Macular Degeneration.